【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 IVD Classification in Australia
2.2.3 The EC (European Commission) Classification
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.1.1 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.2 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.2.1 Challenges in Regulations of MDx tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment Within the In Vitro Diagnostics Market, 2014-2024
3.1 Molecular Diagnostics in the IVD Market, 2013
3.2 Sales Forecast for the Global IVD Market 2014-2024
3.3 Molecular Diagnostics Gaining Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2014-2024
4.1 The Molecular Diagnostic Market by Sectors, 2013
4.2 The Molecular Diagnostic Market by Sectors 2014-2024
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2014-2024
4.3 The Infectious Disease Testing Market 2014-2024
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2013
4.3.1.1 HPV Testing
4.3.1.2 CT/NT
4.3.1.3 HIV
4.3.1.4 Hepatitis C (HCV)
4.3.1.5 MRSA/ C. diff
4.4 The Oncology Testing Market, 2014-2024
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Pipeline Biomarker
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2014-2024
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2014-2024
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potentially Many More Disease Indications
4.6.3 Cystic fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA) Market 2014-2024
4.7.1 Tissue Typing: Next Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2014-2024
5.1 Regional Breakdown of the Global MDx Market, 2013
5.2 The Global MDx Market Forecast 2014-2024
5.3 The Regional Market Shares of the MDx Market, 2014-2024
5.4 The US MDx Market 2013: Representing More than Half of the Global Market
5.4.1 The US MDx Market Forecast 2014-2024
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast, 2014-2024
5.5.1 Changes in the Shares of the Leading European Markets, 2014-2024
5.5.2 The German MDx Market Forecast 2014-2024
5.5.3 The French MDx Market Forecast 2014-2024
5.5.4 The Italian MDx Market Forecast 2014-2024
5.5.5 The Spanish MDx Market Forecast 2014-2024
5.5.6 The UK MDx Market Forecast 2014-2024
5.5.7 The Other European MDx Markets Forecast 2014-2024
5.6 The Japanese MDx Market Forecast 2014-2024
5.7 The Chinese MDx Market Forecast 2014-2024
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2014-2024
5.9 The Russian MDx Market Forecast 2014-2024
5.10 The Indian MDx Market Forecast 2014-2024
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2014-2024
5.12 The Mexican MDx Market Forecast 2014-2024
5.13 The Rest of the World Market Forecast 2014-2024
6. The Leading Companies in the Molecular Diagnostics Market, 2014-2024
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2014-2024
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2013
6.1.3.1 Molecular Diagnostics Sales Performance, 2013
6.1.3.2 Molecular Diagnostic Sales by Region, 2013
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2014
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2014
6.1.4.2 Roche: Recent M&A Activity and Strategic Partnerships
6.2 Hologic Gen-Probe
6.2.1 Hologic Recent Sales Performance by Business Segment, 2013
6.2.2 Hologic Molecular Diagnostics: Product Portfolio
6.2.3 Product Pipeline: Infectious Disease Focus, but Prostate Cancer Diagnostics Shows Promise
6.2.4 Changes in Molecular Diagnostic Operations Structuring
6.3 Qiagen
6.3.1 Sales and Recent Performance Analysis, 2013
6.3.2 Qiagen Sales by Region, 2013
6.3.3 Qiagen Sales by Segment, 2013
6.3.4 Qiagen: Molecular Diagnostics
6.3.5 Molecular Diagnostics: Product Expansion
6.3.5.1 QIASymphony
6.3.5.2 QuantiFERON-TB Gold: Expansion into China
6.3.5.3 Personalised Healthcare: Collaborative Efforts
6.3.5.4 Bioinformatics: Software Company Acquisitions
6.4 Becton, Dickinson & Company
6.4.1 Sales and Financial Performance, 2013
6.4.2 Sales and Financial Performance by Region, 2013
6.4.3 Becton Dickinson Diagnostics Sales and Financial Performance, 2012-2013
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 BioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2013
6.5.2 Sales by Region, 2013
6.5.3 Sales by Technology, 2013
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaboration with GSK
6.5.6 Mergers and Acquisitions
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2013
6.6.2 Sales by Industry Segment, 2012-2013
6.6.3 Sales by Region, 2012-2013
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent (Dako)
6.7.1 Sales and Recent Performance Analysis, 2013
6.7.2 Sales Performance by Business Segment, 2013
6.7.3 Agilent: Strong Player in Next Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2014-2024
7.1 MDx market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2014-2024
7.3 Strength
7.3.1 Patient Demographics
7.3.2 Increased Awareness
7.3.3 High Growth in Oncology Molecular Diagnostics
7.3.4 Increasing Laboratory Test Menus
7.3.5 Personalised Medicine: Optimising Treatment Outcomes
7.4 Weaknesses
7.4.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.4.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.4.2.1 Consolidation of Healthcare Systems Increases Pricing Pressure
7.4.2.2 Reimbursement Uncertainty Discourages Capital Investment
7.4.3 MDx: An Expensive, but Undervalued Diagnostic Tool
7.5 Opportunities
7.5.1 Next-generation Sequencing
7.5.2 Emerging Markets
7.5.3 The Emergence of New Microorganisms
7.6 Threats
7.6.1 US Medical Device Excise Tax
7.6.2 Gene Patents: Controversial Ruling
7.7 Porter’s Five Forces Analysis of the MDx Market
7.7.1 Rivalry Among Competitors [High]
7.7.2 Threat of New Entrants [Medium]
7.7.3 Power of Suppliers [Medium]
7.7.4 Power of Buyers [High]
7.7.5 Threat of Substitutes [High]
8. Expert Opinions
8.1 Mike Nugent, Worldwide Market Segment Leader BD MAX, BD Diagnostics
8.1.1 Becton Dickinson’s Leadership in Infectious Disease Molecular Diagnostics
8.1.2 BD MAX System: Becton Diagnostics Leading Product
8.1.3 The Changing Landscape of the MDx Industry
8.1.4 Cost: A Deterrent of MDx Use
9. Conclusions
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
【レポート販売概要】
■ タイトル：世界の分子診断市場：感染症検査、癌検査、血液検査、遺伝子検査■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2014-2024 : Opportunities for Leading Companies
■ 発行日：2014年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN4120202
■ 調査対象地域：グローバル
- エチレン酢酸ビニルコポリマー(EVA)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world ethylene vinyl acetate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a …
- 警告ラベルおよびシールの世界市場2016-2020About Warning Labels and Stickers A warning label is a label attached to a product or contained in a product's instruction manual, informing the client about the dangers associated with the use of the product. The label may also incorporate restrictions by the producer or seller on specific usages. The majority of the warning labels are used to confine common risks in claims against the product's …
- 尿素ホルムアルデヒドのグローバル市場動向2011-2016（Urea-Formaldehyde (UF) – A Global Market Watch, 2011 – 2016）Global Market Watch: Urea-Formaldehyde (UF) volume market is expected to reach 18.7 million tons by 2016 primarily supported by the product end-user; Fiberboard Wood Composites, Decorative Laminates, Molding Compounds and Plywood. Globally, Fiberboard Wood Composites and Plywood together account for approximately 71.9% of the market share are expected to support the Urea-Formaldehyde (UF) industry …
- 空圧用シールの世界市場2017-2021：シリンダ用シール、バルブ用シールAbout Pneumatic Seals Pneumatic seals are used in pneumatic components like cylinders and valves that are used in applications that involve rotary or reciprocating motions. The seals are used in devices or components that work in low pressure. Minimal lubrication is used in pneumatic seals to ensure a tight seal so that they can be used in devices or components that are exposed to high operating s …
- 地上支援装置（GSE）の世界市場：乗客、貨物、航空機The global ground support equipment (GSE) market has been estimated to be worth USD 12.22 Billion in 2016, and is projected to reach USD 19.44 Billion by 2021, at a CAGR of 9.72%. Some of the key drivers for the growth of the ground support equipment market include rise in air traffic and increasing focus by airports towards enhancing their operational efficiency. The outsourcing of maintenance, r …
- 世界のキラルクロマトグラフィー・カラム（高速液体クロマトグラフィー用など）市場Over the years, the chiral chromatography columns market has witnessed various technological advancements that have led to an increase in the application areas of chiral chromatography columns. For instance, chiral chromatography columns are widely used in academic research laboratories and a number of industries, including pharmaceutical, biotechnology and biopharmaceutical, food and agriculture, …
- ノロウイルスワクチン（Norovirus vaccine）の世界市場機会分析Noroviruses (NVs) called "Norwalk-like viruses" are a group of single-stranded positive sense RNA viruses and members of the family Caliciviridae. NVs are transmitted from human-to-human and are one of the most highly infectious viruses known. In the community, NVs most commonly cause a self-limiting mild disease of short duration with gastrointestinal symptoms usually resolving after 1 to 3 days. …
- 研磨剤の世界市場：天然研磨剤、合成研磨剤、砥石車、紙やすり、被覆砥粒、固定砥粒、超砥粒MarketsandMarkets projects that the abrasives market size will grow from USD 41.21 Billion in 2015 to reach USD 58.43 Billion by 2021, at an estimated CAGR of 6.10%. Acquisitions and new product developments are important strategies taken up by many automotive companies in recent years. The abrasives market has been growing in accordance with the global automotive, metal fabrication, and machinery …
- 人工呼吸器関連肺炎(Ventilator Associated Pneumonia (VAP))の治療薬パイプライン動向（2015年上半期版）Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015’, provides an overview of the Ventilator Associated Pneumonia (VAP)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparati …
- 自動車TJAシステムの世界市場2017-2021About Automotive TJA Systems TJA system is a driver assistance system that assists the driver in navigating through traffic conditions in a hassle-free manner. It is considered as a semi-autonomous feature and is offered as a part of ADAS. It is considered as a modified version of ACC. In ACC, the driver's vehicle can lock onto the vehicle in front and can modulate the vehicle speed depending on t …
- 教育におけるゲーミフィケーションの世界市場予測（～2023年）Increased adoption of digital learning and augmented/virtual reality technologies to drive overall growth of gamification in education market across the globeThe gamification in education market is expected to grow from USD 450 million in 2018 to USD 1,800 million by 2023, at a Compound Annual Growth Rate (CAGR) of 32.0% during the forecast period of 2018–2023. The major factors driving the growth …
- スペインの分子診断市場2014This report provides an overview of the Spanish molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment Market Structure Market Size, Growth, and Major Suppliers' Market Shares List of TablesMolec …
- 医療用接着剤・シール材の世界市場2017-2021About medical adhesives and sealantsMedical adhesives and sealants are usually used for surgical procedures and the bonding of medical appliances. Medical adhesives and sealants are used for the fabrication of an extensive range of medical appliances. These medical appliances are either disposable or can be used several times. Some medical adhesives and sealants are ideal for fixing an extensive r …
- 局所薬物デリバリーの世界市場予測（～2024年）“The topical drug delivery market is projected to grow at a CAGR of 5.7% during the forecast period (2019–2024).”The topical drug delivery market is projected to reach USD 123.2 billion by 2024 from USD 93.2 billion in 2019, at a CAGR of 5.7%. The growth of the topical drug delivery market is driven mainly by the high prevalence of skin disease, rising incidences of eye diseases, high incidence of …
- ラテンアメリカのクラウドコンピューティング市場About Cloud Computing Cloud computing solutions are IT solutions deployed over the ICT systems. These solutions eliminate the need to install in-house hardware and software. The cost of in-house IT solutions is relatively low as compared with cloud-based solutions among most of the IT deployment models. Cloud computing solutions have been implemented in a majority of organizations, irrespective of …
